Navigation Links
Scientists discover mechanism that promotes lung cancer growth and survival
Date:6/18/2012

Richmond, Va. (June 15, 2012) A multi-institutional research study has uncovered a new mechanism that may lead to unique treatments for lung cancer, one of the leading causes of death worldwide.

The study recently published in the journal Genes & Development was a collaboration between Sanford-Burnham Medical Research Institute, Virginia Commonwealth University (VCU) Massey Cancer Center and the VCU Institute of Molecular Medicine, the University of California, San Diego, the University of Minnesota and St. Jude Children's Research Hospital. The scientists discovered that the protein Bax Inhibitor-1 (BI-1) protects lung cancer cells and promotes tumor growth by regulating autophagy, a complex process initiated under stressful conditions that breaks down a cell's own components to provide nutrients needed for survival.

"Cancer cells are remarkably adaptive and depend on a variety of mechanisms to ensure their survival and continued growth when challenged by their environment," says John C. Reed, M.D., Ph.D., professor and CEO of Sanford-Burnham. "By reducing levels of BI-1, it appears we were able to modulate intracellular signals and starve lung cancer cells of the energy needed to carry out one of their most important survival mechanisms, autophagy."

The researchers showed that BI-1 appeared to be linked to levels of calcium, which aids in signal transduction. Suppressing BI-1 reduced calcium levels in the endoplasmic reticulum, the interconnected network of sacs and tubules that manufacture, process and transport a variety of compounds for use inside and outside of cells. Lowering BI-1 levels led to reduced mitochondrial activity, oxygen consumption and adenosine triphosphate (ATP) levels. ATP is often called the "molecular unit of currency" due to the important role it plays in transporting chemical energy needed for metabolism.

The researchers' laboratory findings were confirmed by animal models that showed BI-1 suppression reduced human lung cancer tumor growth.

"These studies are the first to show that BI-1 may play an important survival role in cells under circumstances where oxygen and nutrient deprivation are encountered, such as the conditions that arise in advanced tumors or when cells are stressed by chemotherapy treatments," says Paul B. Fisher, M.Ph., Ph.D., Thelma Newmeyer Corman Endowed Chair in Cancer Research and program co-leader of Cancer Molecular Genetics at VCU Massey Cancer Center, chairman of VCU's Department of Human and Molecular Genetics and director of the VCU Institute of Molecular Medicine. "We are excited by our findings because they uncover a new pathway that may be an effective target for future therapies to treat advanced lung cancer."

Next, the scientists hope to apply their findings to screen for potential drugs that can reduce BI-1-mediated protective autophagy in cancer cells.
'/>"/>

Contact: John Wallace
wallacej@vcu.edu
804-628-1550
Virginia Commonwealth University
Source:Eurekalert

Related medicine news :

1. Scientists Probe Diversity of Human Bodys Microbes
2. Proposed testosterone testing of some female olympians challenged by Stanford scientists
3. Scientists identify possible drug target for acute pancreatitis
4. Scientists Map the Tomatos Genome
5. Scientists discover gene which causes rare disease in babies
6. Scientists evaluate different antimicrobial metals for use in water filters
7. Scientists unravel role of fusion gene in prostate cancer
8. Kessler Foundation scientists present cognitive research findings at MS dual symposium
9. Scientists identify new target to battle rheumatoid arthritis
10. Scientists discover distinct molecular subtype of prostate cancer
11. Scientists study serious immune malfunction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/23/2017)... ... August 23, 2017 , ... Silicon Valley Hair Institute, a leading ... archive organized month-by-month. The new rotation of archived blog posts can provide a wide ... information about hair transplantation can review details online and then reach out for a ...
(Date:8/23/2017)... ... August 23, 2017 , ... ... American Academy of Orthopaedic Surgeons , points out that therapeutic modalities (physical therapy) ... or injury. According to the report, a wider scope of physical therapy options ...
(Date:8/22/2017)... , ... August 22, 2017 , ... The Women’s Choice ... awarded Zyclear Migraine Relief with the 2017 Women’s Choice Award. The identification by women ... that 3 out of 4 migraine sufferers are women. In a survey taken by ...
(Date:8/22/2017)... ... August 22, 2017 , ... ... to announce the addition of Zack Tisch as the firm’s new Consulting Services ... healthcare IT consulting firm’s national accounts, from assisting clients with initial vendor selection ...
(Date:8/22/2017)... (PRWEB) , ... August 22, 2017 , ... Nurses at ... acres at picturesque Babcock Cove, recently received training and certification in Closed Pulse ... which has a prestigious five-star rating from the Centers for Medicare and Medicaid Services, ...
Breaking Medicine News(10 mins):
(Date:8/23/2017)... , Aug. 23, 2017 DarioHealth Corp. ... with mobile health and big data solutions, announced ... placement offerings with domestic and non-U.S. investors for ... stock and shares of the Company,s newly designated ... placement offerings. Current shareholders accounted for 58% of ...
(Date:8/17/2017)... MJAC2017 , the premier cannabis event devoted to retail ... leading lineup. MJAC2017 is proud to ... in the development of pharmaceutical and consumer products, will be ... Green Organic Dutchman are gold sponsors for the event, joined ... ...
(Date:8/15/2017)...   Mostyn Law and Gulf Coast Regional Blood Center ... . The Mostyn Law family has had 3 members ... why Mostyn Law is partnering with Gulf Coast Regional ... appreciation. Blood supplies are running low. Gulf Coast Regional ... needs in August. That is why the blood center reached out ...
Breaking Medicine Technology: